Aminohippuric acid
- Generic Name
- Aminohippuric acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H10N2O3
- CAS Number
- 61-78-9
- Unique Ingredient Identifier
- Y79XT83BJ9
- Background
The glycine amide of 4-aminobenzoic acid. Its sodium salt is used as a diagnostic aid to measure effective renal plasma flow (ERPF) and excretory capacity. [PubChem]
- Indication
Used to measure effective renal plasma flow (ERPF) and to determine the functional capacity of the tubular excretory mechanism.
- Associated Conditions
- -
- Associated Therapies
- -
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Conditions
- Interventions
- First Posted Date
- 2020-12-02
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Yale University
- Target Recruit Count
- 80
- Registration Number
- NCT04649229
- Locations
- 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2
- Conditions
- Interventions
- First Posted Date
- 2019-10-02
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Vanderbilt University Medical Center
- Target Recruit Count
- 80
- Registration Number
- NCT04113109
- Locations
- 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
Evaluation of Lysine-Specific Demethylase 1
- Conditions
- First Posted Date
- 2012-10-08
- Last Posted Date
- 2017-07-12
- Lead Sponsor
- Brigham and Women's Hospital
- Registration Number
- NCT01702688
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Vascular Dysfunction in Diabetes: Genes and Hormones
- Conditions
- First Posted Date
- 2012-01-18
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT01511042
- Locations
- 🇺🇸
Brigham and Women's Hospital- 221 Longwood Avenue, Boston, Massachusetts, United States
Genetic Mechanisms in Human Hypertension
- Conditions
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2021-05-12
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 150
- Registration Number
- NCT01456208
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Caveolin-1 and Vascular Dysfunction
- Conditions
- Interventions
- First Posted Date
- 2011-08-31
- Last Posted Date
- 2022-03-14
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 120
- Registration Number
- NCT01426529
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.